2014
DOI: 10.1097/sle.0000000000000041
|View full text |Cite
|
Sign up to set email alerts
|

Comparison of the Long-term Results of Roux-en-Y Gastric Bypass and Sleeve Gastrectomy for Morbid Obesity

Abstract: RYGB was more effective than SG in the resolution of obesity-related comorbidities, SG was a safer procedure with a reduced rate of complications and reoperation.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

8
60
0
9

Year Published

2015
2015
2023
2023

Publication Types

Select...
6
2

Relationship

0
8

Authors

Journals

citations
Cited by 127 publications
(77 citation statements)
references
References 7 publications
8
60
0
9
Order By: Relevance
“…[24][25][26][27] The present study obtained similar results. The largest BMI reduction at the 6-month follow up was observed for SG (12.29%), and the smallest BMI reduction was observed for LAGB (9.02%).…”
Section: Discussionsupporting
confidence: 80%
See 2 more Smart Citations
“…[24][25][26][27] The present study obtained similar results. The largest BMI reduction at the 6-month follow up was observed for SG (12.29%), and the smallest BMI reduction was observed for LAGB (9.02%).…”
Section: Discussionsupporting
confidence: 80%
“…Several studies have assessed the use of RYGB and compared its outcomes with those of other bariatric procedures. [24][25][26][27] RYGB was shown to very effectively reduce body weight; however, a higher incidence of complications associated with anastomotic leakage, pulmonary embolism, deep vein thrombosis, as well as frequent wound infections and postoperative hernia was observed. In the present study, the patients were qualified for the procedures on the basis of the current guidelines and a number of tests developed by a specialist panel, as well as consultations and each patient's personal commitment.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…It remains controversial whether RYGB and SG lead to comparable rates of metabolic improvement and T2DM remission. Some studies report a higher T2DM remission rate or that glycemic targets can be achieved with fewer medications after RYGB compared with SG surgery (3,22,23,32), while others show a similar glycemic outcome for both procedures (12,16,28,46). Data on longterm remission and relapse rates are scarce, but at 3 years, 38% of those after RYGB and 24% of those after SG had a HbA1c Ͻ42 mmol/l (6%) (39).…”
mentioning
confidence: 98%
“…Po vienerių metų perteklinės kūno masės netekimas lyginant VSR ir STŽAO statistiškai reikšmingai nesiskyrė. Šioje studijoje STŽAO pasižymėjo geresne gretutinių ligų kontrole, tačiau pooperacinių komplikacijų VSR grupėje buvo statistiškai reikšmingai mažiau (9,67 % ir 19,86 %) [26].…”
Section: Rezultataiunclassified